|
CCT251455
|
C647294-5mg
|
≥98% |
1400284-80-1 |
5mg
|
¥ 5000.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
CCT251455
|
C647294-10mg
|
≥98% |
1400284-80-1 |
10mg
|
¥ 8500.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Chrysin 6-C-glucoside 8-C-arabinoside
|
C647276-5mg
|
≥99% |
185145-34-0 |
5mg
|
¥ 4800.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Chrysin 6-C-glucoside 8-C-arabinoside
|
C647276-1mg
|
≥99% |
185145-34-0 |
1mg
|
¥ 1600.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Chrysin 6-C-glucoside 8-C-arabinoside
|
C647276-10mg
|
≥99% |
185145-34-0 |
10mg
|
¥ 8000.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Cy2
|
C647259-5mg
|
Ex:492nm, Em:510nm, ≥98% |
260430-02-2 |
5mg
|
¥ 1900.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Cy2
|
C647259-50mg
|
Ex:492nm, Em:510nm, ≥98% |
260430-02-2 |
50mg
|
¥ 9600.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Cy2
|
C647259-25mg
|
Ex:492nm, Em:510nm, ≥98% |
260430-02-2 |
25mg
|
¥ 6000.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Cy2
|
C647259-10mg
|
Ex:492nm, Em:510nm, ≥98% |
260430-02-2 |
10mg
|
¥ 3000.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Calcipotriol monohydrate
|
C647256-5mg
|
≥99% |
147657-22-5 |
5mg
|
¥ 650.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Calcipotriol monohydrate
|
C647256-50mg
|
≥99% |
147657-22-5 |
50mg
|
¥ 3500.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Calcipotriol monohydrate
|
C647256-10mg
|
≥99% |
147657-22-5 |
10mg
|
¥ 950.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Calcipotriol monohydrate
|
C647256-100mg
|
≥99% |
147657-22-5 |
100mg
|
¥ 5400.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Complement factor D-IN-2
|
C647244-5mg
|
≥99% |
1903742-34-6 |
5mg
|
¥ 7100.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Complement factor D-IN-2
|
C647244-1mg
|
≥99% |
1903742-34-6 |
1mg
|
¥ 2704.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Complement factor D-IN-2
|
C647244-10mg
|
≥99% |
1903742-34-6 |
10mg
|
¥ 11200.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
CCR2 antagonist 3
|
C647230-5mg
|
≥98% |
1380100-86-6 |
5mg
|
¥ 4000.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
CCR2 antagonist 3
|
C647230-50mg
|
≥98% |
1380100-86-6 |
50mg
|
¥ 22000.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
CCR2 antagonist 3
|
C647230-25mg
|
≥98% |
1380100-86-6 |
25mg
|
¥ 13500.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
CCR2 antagonist 3
|
C647230-10mg
|
≥98% |
1380100-86-6 |
10mg
|
¥ 6800.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
CCR2 antagonist 3
|
C647230-100mg
|
≥98% |
1380100-86-6 |
100mg
|
¥ 34000.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
c-Fms-IN-10
|
C647227-5mg
|
≥98% |
1527517-50-5 |
5mg
|
¥ 3500.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
c-Fms-IN-10
|
C647227-50mg
|
≥98% |
1527517-50-5 |
50mg
|
¥ 17000.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
c-Fms-IN-10
|
C647227-25mg
|
≥98% |
1527517-50-5 |
25mg
|
¥ 11000.9
|
期货,请咨询 |
|
0 |
阿拉丁 |